Kiora Pharmaceuticals shares rise 10.14% intraday on technical breakout and short-covering surge.

Kiora Pharmaceuticals fell 10.14% during intraday trading, reversing a previous session's 27% surge driven by technical breakouts and short covering. The decline occurred despite the absence of new fundamental catalysts, as the stock failed to sustain momentum above key resistance levels following an overextended rally. Analysts note that the prior move lacked specific company news, and the subsequent pullback suggests profit-taking and a retest of support near $2.22 as volatility subsided.